[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340937-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340937-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-mirnas-to-detect-progression-stratify-and-predict-relevant-clinical-outcomes-in-bladder-cancer","The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer","","Bladder cancer (BC) is among the most common cancers worldwide, and survival varies substantially with the extent of muscle and surrounding tissue invasion. Early detection and continuous monitoring are therefore critical, yet surveillance cystoscopy is invasive, costly, and uncomfortable. MicroRNAs (miRNAs) are promising prognostic regulators because their expression changes with tumor type and cancer stage and can be measured in liquid samples. This review summarizes recent studies showing miRNA-based multimarker models may outperform traditional approaches in predicting survival, recurrence, and progression, especially when combined with clinicopathological variables, and highlights the need for validation in diverse cohorts and sample types.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-mirnas-to-detect-progression-stratify-and-predict-relevant-clinical-outcomes-in-bladder-cancer/340937/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-mirnas-to-detect-progression-stratify-and-predict-relevant-clinical-outcomes-in-bladder-cancer/340937.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is monitoring bladder cancer important, and what limitations does cystoscopy have?","Question",{"text":63,"@type":64},"Bladder cancer survival depends on invasion degree, so timely detection and monitoring are crucial. Surveillance cystoscopy is invasive, costly, and uncomfortable, creating demand for less invasive alternatives.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do microRNAs (miRNAs) support prognosis and biomarker development in bladder cancer?",{"text":68,"@type":64},"miRNAs act as gene regulators, and their expression is dynamically modified by tumor type and cancer stage. Because they can be evaluated in liquid samples, they are attractive biomarker candidates.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence suggests miRNA-based multimarker models can improve outcome prediction?",{"text":72,"@type":64},"Recent studies reviewed in the text indicate that multimarker miRNA models can predict overall survival, recurrence, and progression better than traditional strategies. Performance is especially improved when miRNA expression is combined with clinicopathological variables.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340937,1790603121,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Review  \nThe Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer  \nMaria Iyali Torres-Bustamante 1, Jorge Raul Vazquez-Urrutia 2, Fabiola Solorzano-Ibarra 3,4 and Pablo Cesar Ortiz-Lazareno 5, *  \nCitation: Torres-Bustamante, M.I.; Vazquez-Urrutia, J.R.;  \nSolorzano-Ibarra, F.;  \nOrtiz-Lazareno, P.C. The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer. Int. J. Mol. Sci. 2024, 25, 2178. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25042178](doi.org/10.3390/ijms25042178)  \nAcademic Editors: Konrad Huppi, Giuseppe Lucarelli and Paola Campomenosi  \nReceived: 18 December 2023  \nRevised: 1 February 2024  \nAccepted: 7 February 2024  \nPublished: 11 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico; [iyali@hotmail.es](iyali@hotmail.es)  \n2 Department of Medicine, The Pennsylvania State University College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA; [jvazquezurrutia@pennstatehealth.psu.edu](jvazquezurrutia@pennstatehealth.psu.edu)  \n3 Instituto de Investigación en Enfermedades Crónico Degenerativas, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico; [fabiolasolorzanoibarra@gmail.com](fabiolasolorzanoibarra@gmail.com)  \n4 Estancias Posdoctorales por México, Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONACYT), México City 03940, Mexico  \n5 División de Inmunología, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Mexico  \n* [Correspondence: pablo.ortiz@imss.gob.mx](Correspondence: pablo.ortiz@imss.gob.mx)  \nAbstract: Bladder cancer (BC) is one of the most common types of cancer worldwide, with significant differences in survival depending on the degree of muscle and surrounding tissue invasion. For this reason, the timely detection and monitoring of the disease are important. Surveillance cystoscopy is an invasive, costly, and uncomfortable procedure to monitor BC, raising the need for new, less invasive alternatives. In this scenario, microRNAs (miRNAs) represent attractive prognostic tools given their role as gene regulators in different biological processes, tissue expression, and their ease of evaluation in liquid samples. In cancer, miRNA expression is dynamically modified depending on the tumor type and cancer staging, making them potential biomarkers. This review describes the most recent studies in the last five years exploring the utility of miRNA-based strategies to monitor progression, stratify, and predict relevant clinical outcomes of bladder cancer. Several studies have shown that multimarker miRNA models can better predict overall survival, recurrence, and progression in BC patients than traditional strategies, especially when combining miRNA expression with clinicopathological variables. Future studies should focus on validating their use in different cohorts and liquid samples.  \nKeywords: miRNAs; bladder cancer; biomarkers; prognosis  \n1. Bladder Cancer Overview  \nBladder cancer (BC) represents the tenth most common cancer in the world and the fourth most common cancer in men in the US [1,2] . Several risk factors associated with the development of this disease have been described, the most well established being tobacco smoking, which is correlated with almost 50% of newly diagnosed BC cases. Other risk factors include the occupational exposure to aluminum, rubber, painting, dyes,","cbCail8fQjdY1qId","https://ap.wps.com/l/cbCail8fQjdY1qId","pdf",1505348,18,"English","# Abstract\n# Bladder Cancer Overview\n## Epidemiology and risk factors\n## Clinical presentation and diagnostic approach\n## Classification, staging, and prognostic differences\n# microRNAs (miRNAs) as biomarkers\n## Role in progression and stratification\n## Potential in predicting clinical outcomes\n# miRNA-based strategies and recent evidence\n## Multimarker miRNA models\n## Integration with clinicopathological variables\n# Future directions for validation","[{\"question\":\"Why is monitoring bladder cancer important, and what limitations does cystoscopy have?\",\"answer\":\"Bladder cancer survival depends on invasion degree, so timely detection and monitoring are crucial. Surveillance cystoscopy is invasive, costly, and uncomfortable, creating demand for less invasive alternatives.\"},{\"question\":\"How do microRNAs (miRNAs) support prognosis and biomarker development in bladder cancer?\",\"answer\":\"miRNAs act as gene regulators, and their expression is dynamically modified by tumor type and cancer stage. Because they can be evaluated in liquid samples, they are attractive biomarker candidates.\"},{\"question\":\"What evidence suggests miRNA-based multimarker models can improve outcome prediction?\",\"answer\":\"Recent studies reviewed in the text indicate that multimarker miRNA models can predict overall survival, recurrence, and progression better than traditional strategies. Performance is especially improved when miRNA expression is combined with clinicopathological variables.\"}]","The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer | PDF",1790039612,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/772e0a9d70886ea770922bc001db33e7.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47081518b30946c6ae284647cc2a3297.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bad0768bca1f12eb984c6cff710b31f.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4409d8b81f986d57a17555bf42462c5b.webp",980,1385]